CTLA4 and neoplasm: The tumor volumes were 2106 ± 205 mm3 on day 17 in the control group treated with vehicle only but were 23 ± 4 mm3 in the group treated with the anti-CTLA-4 antibodies on day 5, which indicated a statistically significant difference in antitumor activity between the treated and vehicle groups [109].